AstraZeneca

News

The unprecedented challenge of pricing a coronavirus vaccine

EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 va...

The European Commission has placed its first advance order for a coronavirus vaccine, snapping up 300 million doses of AstraZeneca’s ChAdOx1 candidate developed by the Universi

News

Redx shares soar after IPF drug licence deal with AstraZenec...

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca.

News

Study puts Jardiance in hot pursuit of AZ’s Farxiga in heart...

The FDA’s approval of AstraZeneca’s SGLT2 inhibitor Farxiga in heart failure was a first for the class, but Boehringer Ingelheim and Eli Lilly are closing the gap with a positi

News

AstraZeneca beats expectations in Q2, while GSK struggles du...

AstraZeneca has beaten analysts’ expectations in its second quarter results, outshining its UK counterpart GlaxoSmithKline, which has been hit by disruption caused by the COVID-19 pandemic.

News

Trial shows AZ's Farxiga slows onset of chronic kidney disea...

AstraZeneca's Farxiga could be on course for another use, after trial results showed it slowed the worsening of renal function and cut the risk of death in patients with chronic kidney dise

News

AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion.

EU places firm order for AZ/Oxford Uni’s ChAdOx1 COVID-19 va...

Redx shares soar after IPF drug licence deal with AstraZenec...

Study puts Jardiance in hot pursuit of AZ’s Farxiga in heart...

AstraZeneca beats expectations in Q2, while GSK struggles du...

Trial shows AZ's Farxiga slows onset of chronic kidney disea...

AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

Syneron raises $150m for macrocylics, and other financings

Using AI-driven synthetic personas to take your insights fur...

AstraZeneca

Editor's Picks